Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56:303–8.

Article  CAS  PubMed  Google Scholar 

Ikejima C, Hisanaga A, Meguro K, Yamada T, Ouma S, Kawamuro Y, et al. Multicentre population-based dementia prevalence survey in Japan: a preliminary report. Psychogeriatrics. 2012;12:120–3.

Article  PubMed  Google Scholar 

Frisoni GB, Fratiglioni L, Fastbom J, Guo Z, Viitanen M, Winblad B. Mild cognitive impairment in the population and physical health: data on 1,435 individuals aged 75 to 95. J Gerontol A Biol Sci Med Sci. 2000;55:M322–8.

Article  CAS  PubMed  Google Scholar 

Mitchell AJ, Shiri-Feshki M. Rate of progression of mild cognitive impairment to dementia–meta-analysis of 41 robust inception cohort studies. Acta Psychiatr Scand. 2009;119:252–65.

Article  CAS  PubMed  Google Scholar 

Roberts R, Knopman DS. Classification and epidemiology of MCI. Clin Geriatr Med. 2013;29:753–72.

Article  PubMed  Google Scholar 

Kishi T, Matsunaga S, Oya K, Ikuta T, Iwata N. Protection against brain atrophy by anti-dementia medication in mild cognitive impairment and Alzheimer’s disease: meta-analysis of longitudinal randomized placebo-controlled trials. Int J Neuropsychopharmacol. 2015. https://doi.org/10.1093/ijnp/pyv070.

Article  PubMed  PubMed Central  Google Scholar 

Tricco AC, Soobiah C, Berliner S, Ho JM, Ng CH, Ashoor HM, et al. Efficacy and safety of cognitive enhancers for patients with mild cognitive impairment: a systematic review and meta-analysis. CMAJ. 2013;185:1393–401.

Article  PubMed  PubMed Central  Google Scholar 

Sugimoto T, Sakurai T, Akatsu H, Doi T, Fujiwara Y, Hirakawa A, et al. The Japan-Multimodal Intervention Trial for Prevention of Dementia (J-MINT): the study protocol for an 18-month, multicenter, randomized, controlled trial. J Prev Alzheimers Dis. 2021. https://doi.org/10.14283/jpad.2021.29.

Article  PubMed  PubMed Central  Google Scholar 

Shimada H, Makizako H, Doi T, Park H, Tsutsumimoto K, Verghese J, et al. Effects of combined physical and cognitive exercises on cognition and mobility in patients with mild cognitive impairment: a randomized clinical trial. J Am Med Dir Assoc. 2018;19:584–91.

Article  PubMed  Google Scholar 

Petersen RC, Lopez O, Armstrong MJ, Getchius TSD, Ganguli M, Gloss D, et al. Practice guideline update summary: mild cognitive impairment: report of the guideline development, dissemination, and implementation subcommittee of the american academy of neurology. Neurology. 2018;90:126–35.

Article  PubMed  PubMed Central  Google Scholar 

Livingston G, Sommerlad A, Orgeta V, Costafreda SG, Huntley J, Ames D, et al. Dementia prevention, intervention, and care. Lancet. 2017;390:2673–734.

Article  PubMed  Google Scholar 

Suzuki T, Shimada H, Makizako H, Doi T, Yoshida D, Ito K, et al. A randomized controlled trial of multicomponent exercise in older adults with mild cognitive impairment. PLoS ONE. 2013;8: e61483.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brodaty H, Heffernan M, Kochan NA, Draper B, Trollor JN, Reppermund S, et al. Mild cognitive impairment in a community sample: the Sydney Memory and Ageing Study. Alzheimers Dement. 2013;9:310-7.e1.

Article  PubMed  Google Scholar 

Suzuki T, Shimada H, Makizako H, Doi T, Yoshida D, Tsutsumimoto K, et al. Effects of multicomponent exercise on cognitive function in older adults with amnestic mild cognitive impairment: a randomized controlled trial. BMC Neurol. 2012;12:128.

Article  PubMed  PubMed Central  Google Scholar 

Lautenschlager NT, Cox K, Kurz AF. Physical activity and mild cognitive impairment and Alzheimer’s disease. Curr Neurol Neurosci Rep. 2010;10:352–8.

Article  PubMed  Google Scholar 

Yokoi K, Nishio Y, Uchiyama M, Shimomura T, Iizuka O, Mori E. Hallucinators find meaning in noises: pareidolic illusions in dementia with Lewy bodies. Neuropsychologia. 2014;56:245–54.

Article  PubMed  Google Scholar 

Swanson CJ, Zhang Y, Dhadda S, Wang J, Kaplow J, Lai RYK, et al. A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody. Alzheimers Res Ther. 2021;13:80.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Salloway S, Chalkias S, Barkhof F, Burkett P, Barakos J, Purcell D, et al. Amyloid-related imaging abnormalities in 2 phase 3 studies evaluating aducanumab in patients with early Alzheimer disease. JAMA Neurol. 2022;79:13–21.

Article  PubMed  Google Scholar 

Matsuda H, Yokoyama K, Sato N, Ito K, Nemoto K, Oba H, et al. Differentiation between dementia with Lewy bodies And Alzheimer’s disease using voxel-based morphometry of structural MRI: a multicenter study. Neuropsychiatr Dis Treat. 2019;15:2715–22.

Article  PubMed  PubMed Central  Google Scholar 

Goto H, Ishii K, Uemura T, Miyamoto N, Yoshikawa T, Shimada K, et al. Differential diagnosis of dementia with Lewy Bodies and Alzheimer Disease using combined MR imaging and brain perfusion single-photon emission tomography. AJNR Am J Neuroradiol. 2010;31:720–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Whitwell JL, Weigand SD, Shiung MM, Boeve BF, Ferman TJ, Smith GE, et al. Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer’s disease. Brain. 2007;130:708–19.

Article  PubMed  Google Scholar 

Middelkoop HA, van der Flier WM, Burton EJ, Lloyd AJ, Paling S, Barber R, et al. Dementia with Lewy bodies and AD are not associated with occipital lobe atrophy on MRI. Neurology. 2001;57:2117–20.

Article  CAS  PubMed  Google Scholar 

Barber R, Gholkar A, Scheltens P, Ballard C, McKeith IG, O’Brien JT. Medial temporal lobe atrophy on MRI in dementia with Lewy bodies. Neurology. 1999;52:1153–8.

Article  CAS  PubMed  Google Scholar 

O’Brien JT, Firbank MJ, Davison C, Barnett N, Bamford C, Donaldson C, et al. 18F-FDG PET and perfusion SPECT in the diagnosis of Alzheimer and Lewy body dementias. J Nucl Med. 2014;55:1959–65.

Article  CAS  PubMed  Google Scholar 

Chiba Y, Iseki E, Fujishiro H, Ota K, Kasanuki K, Suzuki M, et al. Early differential diagnosis between Alzheimer’s disease and dementia with Lewy bodies: comparison between (18)F-FDG PET and (123)I-IMP SPECT. Psychiatry Res Neuroimaging. 2016;249:105–12.

Article  PubMed  Google Scholar 

Massa F, Chincarini A, Bauckneht M, Raffa S, Peira E, Arnaldi D, et al. Added value of semiquantitative analysis of brain FDG-PET for the differentiation between MCI-Lewy bodies and MCI due to Alzheimer’s disease. Eur J Nucl Med Mol Imaging. 2022;49:1263–74.

Article  CAS  PubMed  Google Scholar 

Arbizu J, Festari C, Altomare D, Walker Z, Bouwman F, Rivolta J, et al. Clinical utility of FDG-PET for the clinical diagnosis in MCI. Eur J Nucl Med Mol Imaging. 2018;45:1497–508.

Article  CAS  PubMed  Google Scholar 

Chiba Y, Fujishiro H, Iseki E, Kasanuki K, Sato K. The Cingulate Island Sign on FDG-PET vs. IMP-SPECT to assess mild cognitive impairment in Alzheimer’s disease vs. Dementia with Lewy Bodies. J Neuroimaging. 2019;29:712–20.

Article  PubMed  Google Scholar 

Roberts G, Durcan R, Donaghy PC, Lawley S, Ciafone J, Hamilton CA, et al. Accuracy of cardiac innervation scintigraphy for mild cognitive impairment with Lewy bodies. Neurology. 2021;96:e2801–11.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Thomas AJ, Donaghy P, Roberts G, Colloby SJ, Barnett NA, Petrides G, et al. Diagnostic accuracy of dopaminergic imaging in prodromal dementia with Lewy bodies. Psychol Med. 2019;49:396–402.

Article  PubMed  Google Scholar 

McKeith IG, Ferman TJ, Thomas AJ, Blanc F, Boeve BF, Fujishiro H, et al. Research criteria for the diagnosis of prodromal dementia with Lewy bodies. Neurology. 2020;94:743–55.

Article  PubMed  PubMed Central  Google Scholar 

Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7:270–9.

Article  PubMed  PubMed Central  Google Scholar 

Nakata T, Shimada K, Iba A, Oda H, Terashima A, Koide Y, et al. Correlation between noise pareidolia test scores for visual hallucinations and regional cerebral blood flow in dementia with Lewy bodies. Ann Nucl Med. 2022;36:384–92.

Article  PubMed  Google Scholar 

Ishii K. Diagnostic imaging of dementia with Lewy bodies, frontotemporal lobar degeneration, and normal pressure hydrocephalus. Jpn J Radiol. 2020;38:64–76.

Article  PubMed  Google Scholar 

Walker Z, Jaros E, Walker RW, Lee L, Costa DC, Livingston G, et al. Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy. J Neurol Neurosurg Psychiatry. 2007;78:1176–81.

Article  PubMed  PubMed Central  Google Scholar 

Tatsch K, Poepperl G. Nigrostriatal dopamine terminal imaging with dopamine transporter SPECT: an update. J Nucl Med. 2013;54:1331–8.

Article